To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month supply online for $99, or sign up for an ongoing subscription at $89 a month.
Continuous Glucose Monitoring Devices Market to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9% between 2024 and 2031 BURLINGAME, CA, UNITED STATES, October 15, 2024 /EINPresswire / -- A ...
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
New York, New York-- (Newsfile Corp. - October 12, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and ...
(see more details here). DexCom, Inc. (NASDAQ:DXCM) is a specialty medical devices company that enables diabetics to monitor ...
Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...
SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third ...
A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.